Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Global Source Ventures, LLC (GSV) is a venture capital firm located in San Diego, California. Founded by Antonius 'Toni' Schuh, Ph.D., and Stephen 'Steve' Zaniboni, MBA, CPA, GSV specializes in early-stage investments in life sciences. The firm manages a portfolio of 12 companies and focuses on providing capital, management, and advisory services.
GSV invests in early-stage life sciences companies at the pre-seed, seed, and Series A stages. The firm targets companies developing innovative technologies that can significantly enhance healthcare and sustainability. Investment methods include equity investments, convertible notes, stock options, and warrants.
Notable portfolio companies include Annikki (bio-based alternatives to chemicals), Avalyn Pharmaceuticals (therapies for idiopathic pulmonary fibrosis), Immusoft (immune cell treatments), Oncternal (novel cancer therapies), Retrotope (mitochondrial health preservation), Telephus Medical (monoclonal antibody for staph infections), Soluventis Nanotherapeutics (RNA-based therapeutics delivery), Treemera (bio-based polymers), Velos BioPharma (antibody drug candidate platform), Zavante (therapies for serious infections), and RetroSense Therapeutics (gene therapies for vision restoration).
Submit your pitch through their form at globalsourceventures.com or email info@globalsourceventures.com with your deck.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.